Did you suffer an eye injury after taking Elmiron?

YOU MAY BE ELIGIBLE FOR FINANCIAL COMPENSATION. COMPLETE THE FORM FOR A FREE CASE EVALUATION.

OUR PERSONAL INJURY ATTORNEYS ARE REVIEWING CLAIMS ON BEHALF OF INTERSTITIAL CYSTITIS PATIENTS WHO TOOK THE PRESCRIPTION DRUG ELMIRON AND ARE SUFFERING FROM A SEVERE EYE DISEASE CALLED MACULOPATHY

The Elmiron lawsuits are legal claims for money damages brought by consumers who took the prescription drug Elmiron to treat a chronic bladder condition called interstitial cystitis.  These lawsuits allege that long-term Elmiron use causes pigmentary maculopathy which is an eye disorder affecting the macula in the central part of the retina and a major cause of permanent vision loss, distorted vision and blindness.

Recently, dozens of individuals from across the United States have taken legal action and filed Elmiron Lawsuits with the help of experienced attorneys alleging that their use of Elmiron has caused retinal injuries and vision damage, notably atypical or pigmentary maculopathy.  The medication insert produced by Elmiron’s drug maker did not include any warning regarding the risk factors or dangerous side effects and vision issues or eye disease until a warning was added about pigmentary maculopathy in June of 2020. These lawsuits (often referred to as mass torts) seek compensation for Elmiron victims from the drug manufacturers and have been consolidated, through a legal process known as multidistrict litigation, into the Elmiron MDL.  The Elmiron MDL is in the discovery phase of the case and is being handled in the United States District Court District of New Jersey before Judge Brian Martinotti and Judge Edward Kiel.  Soon, some these Elmiron MDL cases will be selected to proceed as a bellwether trial and the outcome of these trials will have a large impact on the remaining Elmiron MDL cases.

Elmiron vision loss lawsuit lawyers

If you or a loved one has been suffered vision loss or other eye issues after taking Elmiron (pentosan polysulfate sodium), contact the aggressive defective drug lawsuit lawyer Matthew Marin of the Marin and Barrett, Inc. law firm to find out how we can help.  Elmiron lawyer Matthew Marin has been ranked as a top attorney by the SuperLawyers organization as a “Rising Star” and now a “SuperLawyer” from 2014 through 2022. Call to schedule a free, no obligation case evaluation today. Our personal injury lawyers are available 24/7 at (888) 348-2735 to take your call and stand ready to fight for the financial compensation you deserve.

The Latest Elmiron Updates

October 26, 2022: Elmiron vision loss lawsuits pending in federal court will continue to be delayed until March 2023, according to the U.S. District Judge presiding over all lawsuits. The jury trial will be closely watched for the response to certain evidence and testimony that will be repeated across hundreds of cases.
October 12, 2022: This month, despite some delays and modifications to the bellwether schedule in the Elmiron MDL, the first bellwether trial is expected to begin in January 2023. These bellwether trials will help other Elmiron plaintiffs and defendants, including Teva Pharmaceuticals and Bayer AG, help gauge how the evidence will unfold in these cases. They will also provide key insight into how juries are likely to respond to the evidence and testimony about permanent vision damage caused by Elmiron. The presentation of similar evidence and testimony in other Elmiron trials will be repeated throughout hundreds of cases pending in the federal court system.

Did you suffer an eye injury after taking Elmiron?

YOU MAY BE ELIGIBLE FOR FINANCIAL COMPENSATION. COMPLETE THE FORM FOR A FREE CASE EVALUATION.